Marlala Posted - 15 hours ago

$BMRN $SGMO

BurkeTheBizarre15 Posted - 15 hours ago

$SGMO they are comparing it to $BMRN and saying it could out perform

DonCorleone77 Posted - 2 days ago

$BMRN BioMarin announces FDA approval of sBLA for BRINEURA BioMarin Pharmaceutical announced that the U.S. FDA has approved the company's supplemental Biologics License Application for BRINEURA to slow the loss of ambulation in children of all ages with neuronal ceroid lipofuscinosis type 2, also known as tripeptidyl peptidase 1 deficiency. Previously, BRINEURA was indicated in symptomatic children 3 years of age and older with late infantile CLN2 disease. This expanded indication now includes children of all ages with CLN2 disease, regardless of whether they are symptomatic or presymptomatic.

RockyTSTH Posted - 2 days ago

$BMRN U.S. FDA Approves BioMarin's BRINEURA For Children Under 3 Years With CLN2 Disease

Stock_Titan Posted - 2 days ago

$BMRN U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease https://www.stocktitan.net/news/BMRN/u-s-food-and-drug-administration-approves-bio-marin-s-brineura-r-mvp0i482w84r.html

Herr_Chicken Posted - 2 days ago

@steven1x Yes, especially with Peter Marks at the FDA. Pfizer just needs to make sure they prepare a good package and avoid the troubles $BMRN had with Roctavian approval/launch. I think BLA submission would not occur until early 2025 though; that was always the timeline discussed. The BLA triggers a milestone for $SGMO but I'm not sure how much.

Herr_Chicken Posted - 2 days ago

$SGMO The question will be, do these results from $PFE's hem A gene Tx beat $BMRN's Roctavian? That will be an important factor in whether SB525 goes forward to market, I would think. The results seem pretty impressive to me although I would have to dig deeper into the 20% adverse reaction rate of SB525 vs whatever it is for Roctavian. All in all this is a positive readout though. Happy for Sandy and the Sangamo team and all my fellow Sangamo-ans on this board.

Top_Dog_Pro_Trader Posted - 2 days ago

$PFE AFFINE results are huge, means they have cornered the HemA market. Per Wedbush HemA Drs and Patients were waiting for AFFINE results … why they weren’t taking Roctavian! $BMRN

Top_Dog_Pro_Trader Posted - 2 days ago

$BMRN $PFE as I was saying … the AFFINE results means Roctavian is Das Kaput!

Stock_Titan Posted - 3 days ago

$BMRN BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET https://www.stocktitan.net/news/BMRN/bio-marin-to-host-second-quarter-2024-financial-results-conference-sxrcr115yuc8.html

intratio Posted - 2 weeks ago

https://www.intratio.com/stock-forecast/BMRN BIOMARIN PHARMACEUTICAL INC Our artificial intelligence concludes that the value of this equity will hedge lower in the short-term and has a dismal outlook for the future $BMRN

intratio Posted - 2 weeks ago

$BMRN https://www.intratio.com/stock-forecast/BMRN BIOMARIN PHARMACEUTICAL INC Our trained A.I. calculated this stock s price is not likely to rise soon with a pessimistic long-term perspective

EagleMan1 Posted - 2 weeks ago

$EYEN $BMRN and $ZLAB and $VYNE and $ALIM What is new and opportunity in $EYEN? The stock is $EYEN. ==> fair value 11.09 1 - Insider bought 1.5 million shares in July and paid 1 Million dollars 2 - Vanguard biggest institution in the world bought 5 million dollars for a call option 3 - First FDA MydCombi selling from April 2024, and they have a contract with Vision Source biggest Private Practice Optometrists in the USA and Canada. Vision Source multi a billion company. 4 - Second FDA's strongest eyedrop sales start the first of August and are expected to generate 15 to 40 million per quarter. 5 - 8 or 9 August earnings call, and it should be good. 6 - MicroPine and MicroLine are unmet need eyedrops for children and the result is coming in Q4 2024.

TickerDD_com Posted - 3 weeks ago

From 6/26/2024, looking back across 21 Month-Ends for BMRN, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $BMRN #BMRN #BMRNStock #TickerDD #BMRNPrice https://www.youtube.com/watch?v=VKr2ndT1n30

biotech Posted - 4 weeks ago

$SGMO CEO more bullish comments on $PFE Hemophilia A phase 3 VS $BMRN Valrox @ HCW

intratio Posted - 1 month ago

$BMRN The model is forecasting that this company s market value will not rise in the near future with a pessimistic long-term perspective

NervyBiotechs Posted - 1 month ago

$BMRN @Top_Dog_Pro_Trader Hey Top_Doggy! Not buying your extreme negativity. Inconsistent with all your postings pre May 10th. You've changed your position IMO - gone short I'd say. Your opinion has lost its value.

jjmstocks1 Posted - 1 month ago

$BMRN we gonna fill this gap up or what?

intratio Posted - 1 month ago

$BMRN https://www.intratio.com/stock-forecast/BMRN Our algorithm reaches the conclusion this company s stock price will decrease in the near future and is facing significant downsides in the longer term

ItsMeMP3 Posted - 1 month ago

$BMRN whats your price target?

intratio Posted - 1 month ago

https://www.intratio.com/stock-forecast/BMRN The statistical model computed that this company s market value will go south in the coming week and is facing significant downsides in the longer term $BMRN

intratio Posted - 1 month ago

Our model is forecasting that the value of this equity will hedge lower in the short-term and holds little hope for the future $BMRN

johnnyapples123 Posted - 1 month ago

$BMRN textbook shakeout

Top_Dog_Pro_Trader Posted - 1 month ago

$BMRN take profits is my advice. When PFE’s HemA PhIII results come out, that will wipe out most of BMRN’s future, and any hope for a suitor. Be grateful that the SP has recouped some of the recent losses. Keep in mind that some Analysts had Rox contributing between 60%—200% of revenue.

bearcharts Posted - 1 month ago

Sold $BMRN at target 86, something I've been trying to do since I acquired it via short-put assignment back on May 18th. I also have a credit call spread now at the money for this Friday. I'll write OTM credit put spreads again now.

BioRich Posted - 1 month ago

@Howsweet24 I think it's been leaked. $SRPT $LLY $PFE $BMRN

Aigner_Andreas Posted - 1 month ago

TD SELL $BMRN at 84.24, Supp 74.43 Resis 84.55 R14 HiLo 40% T1Y 113 buy 1.9 DIV N/A #Biomarin P #stocks #trading #finance #market

biotech Posted - 1 month ago

@scienceleads $BMRN safety looks what ? they lied on bleed reduction and FDA lowered it to 52 from reported 85 or so , LIVER has to be monitored , you have to take steroids and youre not allowed to drinc any alcohol , noone whats this shit

scienceleads Posted - 1 month ago

$BMRN reported that bmrn is entering the s&p400 index (not new news)

biotech Posted - 1 month ago

$SGMO CEO talking $PFE Hemophilia A GT middle of the year "That launch will be much more effective" (than $BMRN) milestone on filing $220m next 18 months then 14-20% of sales https://x.com/i/status/1799545830744953150